During the past decade, Sarasota Memorial Hospital conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 39 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 16 clinical trials were completed. i.e. 48.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sarasota Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "Gynecologic Oncology Group" with 9 trials sponsored, "Abbott Medical Devices" with 8 trials sponsored, "Boston Scientific Corporation" with 7 trials sponsored and "Edwards Lifesciences" with 7 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sarasota Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Columbia University" with 2 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "Sarasota Memorial Hospital" are "Heart Failure" (10 trials), "Coronary Artery Disease" (8 trials), "Breast Cancer" (7 trials), "Endometrial Clear Cell Adenocarcinoma" (6 trials) and "Endometrial Serous Adenocarcinoma" (6 trials). Many other conditions were trialed in "Sarasota Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Sarasota Memorial Hospital" are "Drug" (59 trials), "Device" (45 trials), "Other" (34 trials), "Procedure" (18 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (15 trials), "Quality-of-Life Assessment" (15 trials), "Laboratory Biomarker Analysis" (11 trials), "Carboplatin" (10 trials) and "Placebo" (10 trials). Other intervention names were less common.

The vast majority of trials in "Sarasota Memorial Hospital" are 83 trials for "All" genders and 40 trials for "Female" genders.

Currently, there are NaN active trials in "Sarasota Memorial Hospital". undefined are not yet recruiting, 22 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 57 completed trials in Sarasota Memorial Hospital, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Sarasota Memorial Hospital, 3 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 35 trials that are defined as “Not Applicable".

Sarasota Memorial Hospital has several departments that took part in Clinical trials: "Sarasota Radiation and Medical Oncology Center" - 34 trials, "Sarasota Memorial Health Care System; Cancer Research Program" - 2 trials, "Sarasota Memorial Pain Care Center" - 2 trials